Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HETEROCYCLIC GLP-1 AGONISTS
Document Type and Number:
WIPO Patent Application WO/2023/198140
Kind Code:
A1
Abstract:
The present disclosure relates generally to GLP-1 agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.

Inventors:
LIN XICHEN (CN)
MENG QINGHUA (CN)
XING WEIQIANG (CN)
JENNINGS ANDREW (US)
Application Number:
PCT/CN2023/087997
Publication Date:
October 19, 2023
Filing Date:
April 13, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GASHERBRUM BIO INC (US)
LIN XICHEN (CN)
International Classes:
C07D405/14; A61K31/437; A61K31/454; A61K31/497; A61P3/10; A61P9/12; A61P25/16; C07D417/14
Domestic Patent References:
WO2022078407A12022-04-21
WO2020103815A12020-05-28
WO2020234726A12020-11-26
WO2020044266A12020-03-05
WO2010140092A12010-12-09
WO2010128425A12010-11-11
WO2010128414A12010-11-11
WO2010106457A22010-09-23
WO2010103437A12010-09-16
WO2010103438A12010-09-16
WO2010013161A12010-02-04
WO2007122482A12007-11-01
WO2006112549A12006-10-26
WO2007028135A22007-03-08
WO2008047821A12008-04-24
WO2008050821A12008-05-02
WO2008136428A12008-11-13
WO2008156757A12008-12-24
WO2005116034A12005-12-08
WO2010011439A22010-01-28
WO2010023594A12010-03-04
WO2009144554A12009-12-03
WO2003072197A12003-09-04
WO2009144555A12009-12-03
WO2008065508A12008-06-05
WO2001014372A22001-03-01
WO2004039365A12004-05-13
WO1997010224A11997-03-20
WO2000001389A12000-01-13
WO2002006234A12002-01-24
WO2004048363A12004-06-10
WO2005030740A12005-04-07
WO2005058823A12005-06-30
WO2005113504A12005-12-01
WO2009016462A22009-02-05
WO2010086820A12010-08-05
WO2020117987A12020-06-11
WO2007013694A12007-02-01
WO2007018314A22007-02-15
WO2008093639A12008-08-07
WO2008099794A12008-08-21
WO2004041266A12004-05-21
WO2004106276A12004-12-09
WO2005063729A12005-07-14
WO2005063725A12005-07-14
WO2005087710A12005-09-22
WO2005095338A12005-10-13
WO2007013689A12007-02-01
WO2008001931A22008-01-03
WO2009080351A12009-07-02
WO2019203753A22019-10-24
WO2002020001A22002-03-14
WO2006111169A12006-10-26
Foreign References:
US10370426B22019-08-06
US10308700B22019-06-04
US10259823B22019-04-16
US10208019B22019-02-19
US9920106B22018-03-20
US9839664B22017-12-12
US8129343B22012-03-06
US8536122B22013-09-17
US7919598B22011-04-05
US6414126B12002-07-02
US6628343B12003-09-30
US20060275288A12006-12-07
US20120021979A12012-01-26
US20120148586A12012-06-14
US8859577B22014-10-14
US20050287100A12005-12-29
US20180051012A12018-02-22
US5612359A1997-03-18
US6043265A2000-03-28
US20120101089A12012-04-26
US10071088B22018-09-11
US6673792B12004-01-06
US6197329B12001-03-06
US10828297B22020-11-10
US10322106B22019-06-18
US10525033B22020-01-07
US8119697B22012-02-21
US5039528A1991-08-13
US20090305964A12009-12-10
Other References:
KARLA ET AL.: "Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future", INDIAN J ENDOCRINOL METAB., vol. 20, no. 2, March 2016 (2016-03-01), pages 254 - 267
"Remington: The Science and Practice of Pharmacy", 2012, LIPPINCOTT WILLIAMS & WILKINS
"Pharmaceutical Preformulation and Formulation", 2009, THE PHARMACEUTICAL PRESS AND THE AMERICAN PHARMACEUTICAL ASSOCIATION
ZHANG ET AL., DRUG DISCOVERY TODAY, vol. 12, no. 9-10, 2007, pages 373 - 381
SKELLY ET AL., J HEPATOL, vol. 1-2, 2001, pages 195 - 9
CHITTURI ET AL., HEPATOLOGY, vol. 35, no. 2, 2002, pages 373 - 9
ANGULO ET AL., J GASTROENTEROL HEPATOL, vol. 17, 2002, pages 186 - 90
VIRDEE ET AL., OPHTHALMOL THER., vol. 9, no. 4, 2020, pages 767 - 781
SEPPA ET AL., SCI REP, vol. 9, 2019, pages 15742
BERHMAN REKLIEGMAN RARVIN AMNELSON WE: "Nelson Textbook of Pediatrics", 1996, PHILADELPHIA: W.B. SAUNDERS COMPANY
RUDOLPH AM ET AL.: "Rudolph's Pediatrics", 2002, MCGRAW-HILL
AVERY MD: "Pediatric Medicine", 1994, BALTIMORE: WILLIAMS & WILKINS
Attorney, Agent or Firm:
WU , FENG & ZHANG (CN)
Download PDF: